secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ocean Biomedical, Inc. (OCEA)
CIK:        0001869974
Form:       8-K
Filed at:   2023-11-15T23:59:59+00:00
Accession:  0001493152-23-041387
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 4.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ocean Biomedical restates Q1/Q2 2023 financials over Backstop Agreement classification error
--------------------------------------------------------------------------------

- Audit Committee on Nov 10 concluded prior Q1 and Q2 2023 financials should no longer be relied upon.
- Issue follows SEC Staff interpretation on Forward Purchase Agreements; prepayment recorded as asset instead of equity.
- Prepaid forward transaction and minimum maturity consideration should be classified as liabilities.
- Prior earnings releases, guidance, and investor communications referencing those statements also unreliable.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1869974/000149315223041387/0001493152-23-041387-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1869974/000149315223041387/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-041387

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer